Envision Pharma Group

Envision Pharma Group combines medical communications, strategic consulting, and technology across medical affairs, evidence and value, commercial strategy, and patient engagement. Its core work spans publication planning, scientific communications strategy, and value dossiers, supported by its iEnvision and Datavision platforms and by managed services.

Medical Affairs Planning and Publications

• Medical affairs teams can plan scientific priorities, evidence generation, publications, and impact measurement through strategic services and iEnvision workflows connecting planning, execution, governance, and performance data.
• Publication teams can manage publication planning, execution, and reporting through Datavision. Envision's medical communications experts develop scientific communications strategy and write manuscripts and plain-language patient summaries, with AI speeding up first drafts.

Advisory Boards, Insights and Field Engagement

• Medical affairs teams can run advisory boards, scientific meetings, and HCP communities with Envision, and test questions first in simulated advisory boards, where its consultants moderate AI-generated expert personas built from published literature and clinical guidelines.
• Envision's AI-enabled teams distill themes from HCP and patient advisory boards and extract insights from MSL interactions, and its Insight Generator is an AI-powered medical intelligence platform for medical affairs and patient advocacy.
• Envision also trains and engages MSL and field force teams, and runs strategic stakeholder mapping and engagement.

Evidence, Value, and Access Decisions

• Envision's value and evidence services cover integrated evidence strategy, literature reviews, and global and local value dossiers that help prove product value across the lifecycle.
• Medical affairs teams can manage investigator-sponsored research and grant review and funding through governed iEnvision workflows. The platform also supports expanded access review and decision-making while maintaining compliance.

Commercial and Stakeholder Strategy

• Commercial and portfolio leaders can use strategic consulting for product, portfolio, launch, market-entry, research, benchmarking, forecasting, valuation, and post-launch optimization.
• Strategy teams can monitor pipelines, market evolution, competitor activity, congress developments, and emerging data through competitive intelligence, event reporting, alerts, and insight-led analysis. Stakeholder research covers KOL, HCP, payer, and patient perspectives.

Patient Engagement and Recruitment

• Patient and clinical teams can use patient support services, hub strategy and operations, patient journey mapping, and clinical trial engagement and recruitment strategy and execution.
• Patient insight teams can apply social listening and insights from an in-house Patient Panel to support patient education, community engagement, and communications.

Best Fit

• Biopharmaceutical organizations seeking a combined partner for medical affairs strategy, publication operations, scientific communications, evidence planning, and value communication.
• Teams that need consulting and managed services alongside iEnvision technology for governed medical affairs workflows, investigator research, grants, expanded access, and performance insight.